Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models LM Ittner, YD Ke, F Delerue, M Bi, A Gladbach, J van Eersel, H Wölfing, ... Cell 142 (3), 387-397, 2010 | 1928 | 2010 |
Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease LM Ittner, J Götz Nature Reviews Neuroscience 12 (2), 67-72, 2011 | 1507 | 2011 |
Animal models of Alzheimer's disease and frontotemporal dementia J Götz, LM Ittner Nature Reviews Neuroscience 9 (7), 532-544, 2008 | 824 | 2008 |
Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice V Rhein, X Song, A Wiesner, LM Ittner, G Baysang, F Meier, L Ozmen, ... Proceedings of the National Academy of Sciences 106 (47), 20057-20062, 2009 | 712 | 2009 |
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease KS Lang, M Recher, T Junt, AA Navarini, NL Harris, S Freigang, ... Nature medicine 11 (2), 138-145, 2005 | 453 | 2005 |
Tau aggregation and its interplay with amyloid-β RM Nisbet, JC Polanco, LM Ittner, J Götz Acta neuropathologica 129, 207-220, 2015 | 350 | 2015 |
The frontotemporal dementia-motor neuron disease continuum JR Burrell, GM Halliday, JJ Kril, LM Ittner, J Götz, MC Kiernan, JR Hodges The Lancet 388 (10047), 919-931, 2016 | 329 | 2016 |
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models J Van Eersel, YD Ke, X Liu, F Delerue, JJ Kril, J Götz, LM Ittner Proceedings of the National Academy of Sciences 107 (31), 13888-13893, 2010 | 298 | 2010 |
Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-β N Schonrock, YD Ke, D Humphreys, M Staufenbiel, LM Ittner, T Preiss, ... PloS one 5 (6), e11070, 2010 | 250 | 2010 |
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice A Ittner, SW Chua, J Bertz, A Volkerling, J Van Der Hoven, A Gladbach, ... Science 354 (6314), 904-908, 2016 | 245 | 2016 |
Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling M Kléber, HY Lee, H Wurdak, J Buchstaller, MM Riccomagno, LM Ittner, ... The Journal of cell biology 169 (2), 309-320, 2005 | 237 | 2005 |
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia LM Ittner, T Fath, YD Ke, M Bi, J Van Eersel, KM Li, P Gunning, J Götz Proceedings of the National Academy of Sciences 105 (41), 15997-16002, 2008 | 229 | 2008 |
Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease YD Ke, F Delerue, A Gladbach, J Götz, LM Ittner PloS one 4 (11), e7917, 2009 | 217 | 2009 |
Primary support cultures of hippocampal and substantia nigra neurons T Fath, YD Ke, P Gunning, J Götz, LM Ittner Nature protocols 4 (1), 78-85, 2009 | 215 | 2009 |
Pronuclear injection for the production of transgenic mice LM Ittner, J Götz Nature protocols 2 (5), 1206-1215, 2007 | 211 | 2007 |
Design of custom-shaped vascularized tissues using microtissue spheroids as minimal building units JM Kelm, V Djonov, LM Ittner, D Fluri, W Born, SP Hoerstrup, ... Tissue engineering 12 (8), 2151-2160, 2006 | 207 | 2006 |
Dendritic tau in Alzheimer’s disease A Ittner, LM Ittner Neuron 99 (1), 13-27, 2018 | 201 | 2018 |
A decade of tau transgenic animal models and beyond J Götz, N Deters, A Doldissen, L Bokhari, Y Ke, A Wiesner, N Schonrock, ... Brain Pathology 17 (1), 91-103, 2007 | 199 | 2007 |
Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice M Bi, A Ittner, YD Ke, J Götz, LM Ittner PloS one 6 (12), e26860, 2011 | 180 | 2011 |
Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease LM Ittner, YD Ke, J Götz Journal of Biological Chemistry 284 (31), 20909-20916, 2009 | 180 | 2009 |